Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP)
Brian D. Klein, Catherine Jacobson, Cameron S. Metcalf, et al.
Neurochemical Research (2017) Vol. 42, Iss. 7, pp. 1939-1948
Closed Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Mechanisms of action of currently used antiseizure drugs
Graeme J. Sills, Michael A. Rogawski
Neuropharmacology (2020) Vol. 168, pp. 107966-107966
Open Access | Times Cited: 366
A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis
Paula Berman, Kate Futoran, Gil M. Lewitus, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 238
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
Emilio Perucca
Journal of Epilepsy Research (2017) Vol. 7, Iss. 2, pp. 61-76
Open Access | Times Cited: 208
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 198
The proposed mechanisms of action of CBD in epilepsy
Royston A. Gray, Benjamin J. Whalley
Epileptic Disorders (2020) Vol. 22, Iss. S1
Open Access | Times Cited: 167
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
Valentina Franco, Emilio Perucca
Drugs (2019) Vol. 79, Iss. 13, pp. 1435-1454
Closed Access | Times Cited: 147
Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). I. Drugs in preclinical and early clinical development
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2020) Vol. 61, Iss. 11, pp. 2340-2364
Open Access | Times Cited: 137
Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
Pabitra Hriday Patra, Melissa Barker‐Haliski, H. Steve White, et al.
Epilepsia (2018) Vol. 60, Iss. 2, pp. 303-314
Open Access | Times Cited: 137
Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer’s disease
Han Li, Yuzhi Liu, Danni Tian, et al.
European Journal of Medicinal Chemistry (2020) Vol. 192, pp. 112163-112163
Closed Access | Times Cited: 132
An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy
Yi Wang, Chen Zhong
Pharmacology & Therapeutics (2019) Vol. 201, pp. 77-93
Closed Access | Times Cited: 126
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 106
Cannabidiol in the Treatment of Epilepsy
Randi von Wrede, Christoph Helmstaedter, Rainer Surges
Clinical Drug Investigation (2021) Vol. 41, Iss. 3, pp. 211-220
Open Access | Times Cited: 88
Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy
Debopam Samanta
Pediatric Neurology (2019) Vol. 96, pp. 24-29
Closed Access | Times Cited: 77
Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research
Valentina Franco, Meir Bialer, Emilio Perucca
Neuropharmacology (2021) Vol. 185, pp. 108442-108442
Closed Access | Times Cited: 57
Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies
Doodipala Samba Reddy
Experimental Neurology (2022) Vol. 359, pp. 114237-114237
Open Access | Times Cited: 50
Cannabidiol goes nuclear: The role of PPARγ
Sara Khosropoor, Mohaddeseh Sadat Alavi, Leila Etemad, et al.
Phytomedicine (2023) Vol. 114, pp. 154771-154771
Closed Access | Times Cited: 28
Cannabidiol and brain function: current knowledge and future perspectives
Moniek Schouten, Sebastiaan Dalle, Dante Mantini, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 8
Cannabidiol y epilepsia: avances en su investigación como opción terapéutica
Cecilia Zavala‐Tecuapetla, Ana Canseco-Alba, Joaquín Manjarrez-Marmolejo, et al.
eNeurobiología (2025) Vol. 16, Iss. 40
Open Access | Times Cited: 1
The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy
Karen S. Wilcox, Peter J. West, Cameron S. Metcalf
Neuropharmacology (2019) Vol. 166, pp. 107811-107811
Open Access | Times Cited: 70
<p>Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects</p>
Alessandra Morano, Martina Fanella, Mariarita Albini, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 381-396
Open Access | Times Cited: 66
Cannabinoid therapy in epilepsy
Santoshi Billakota, Orrin Devinsky, Eric D. Marsh
Current Opinion in Neurology (2019) Vol. 32, Iss. 2, pp. 220-226
Closed Access | Times Cited: 65
Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening
Melissa Barker‐Haliski, H. Steve White
Neuropharmacology (2019) Vol. 167, pp. 107750-107750
Open Access | Times Cited: 62
The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights
Willian Lazarini-Lopes, Raquel A. Do Val-da Silva, Rui Milton Patrício da Silva-Júnior, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 111, pp. 166-182
Closed Access | Times Cited: 62
Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials
Orrin Devinsky, Elizabeth A. Thiele, Stephen Wright, et al.
Acta Neurologica Scandinavica (2020) Vol. 142, Iss. 6, pp. 531-540
Open Access | Times Cited: 54
Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
Marcin Ożarowski, Tomasz M. Karpiński, Aleksandra Zielińska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4294-4294
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top